Ivím Health
US$ 24.13
surmount-1 trial tirzepatide weight loss nondiabetic Delivers in SURMOUNT-2 Semaglutide vs. Tirzepatide for Obesity
Description
Aprs l'Ozempic et le Wegovy, place dsormais au Mounjaro
This safeguard ensures the drug is used safely and only when appropriate
Escalation: Step up to 5 mg for Weeks 58, then 7.5 mg for Weeks 912 [1]
When your daily target is 1,200-1,500 calories, one side of fries consumes 25-30% of your allowance with minimal protein and no meaningful micronutrients
Other weight loss injections, such as Wegovy, also follow their own dosing schedule
Avoid simple sugars and refined carbohydrates that offer minimal nutritional value
